Why is Aarti Pharma falling/rising?

As of 29-Jul, Aarti Pharmalabs Ltd's stock price is rising, currently at Rs 939.00, reflecting an increase of Rs 16.6 or 1.8%. The stock has shown strong performance, with a 1-week return of +0.29% and a 1-month return of +9.28%, significantly outperforming the Sensex, which has seen a decline of -1.03% and -3.24% respectively. Today's price summary indicates that the stock is close to its 52-week high, being only 3.46% away from Rs 971.5, and it reached an intraday high of Rs 952. Despite a slight decrease in investor participation, the company demonstrates strong financial health with a low Debt to EBITDA ratio of 0.63 times and impressive quarterly results, including a 41.7% growth in profit before tax.
In the broader market context, Aarti Pharmalabs has outperformed the benchmark, as evidenced by its substantial 57.14% return over the past year compared to the BSE500's negative return of -2.26%. This performance is bolstered by the company's attractive valuation metrics and strong ability to service debt, although concerns about long-term growth and decreasing promoter confidence could pose risks. The recent reduction in promoter stake by 0.57% may indicate some uncertainty regarding the company's future, but the overall market-beating performance and positive financial indicators have contributed to the stock's upward movement.